ArticleThe Journal of clinical endocrinology and metabolism2016

Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.

Polyzois Makras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.